Amphastar Pharmaceuticals (AMPH) Share-based Compensation Growth (1y) (2014 - 2026)
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) Share-based Compensation Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.57 Bn | 38.91 Bn | 2.15 Bn | 5.26% |
| 2 | Viatris | 19.20 Bn | 18.31 Bn | 1.46 Bn | -18.06% |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | -21.71% |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | -6.88% |
| 5 | Bausch Health Companies | 2.36 Bn | 520.75 Mn | 2.10 Bn | 17.39% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 18.79% |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn | 12.69% |
| 9 | Fennec Pharmaceuticals | 406.25 Mn | 365.00 Mn | 17.15 Mn | -17.19% |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.69% |
| Mar 31, 2026 | 10.50% |
| Dec 31, 2025 | 10.17% |
| Sep 30, 2025 | 252.87% |
| Jun 30, 2025 | 272.17% |
| Mar 31, 2025 | 14.04% |
| Dec 31, 2024 | 21.85% |
| Sep 30, 2024 | -14.23% |
| Jun 30, 2024 | -13.12% |
| Mar 31, 2024 | -13.68% |
| Dec 31, 2023 | 7.39% |
| Sep 30, 2023 | -1.22% |
| Jun 30, 2023 | -0.33% |
| Mar 31, 2023 | 2.05% |
| Dec 31, 2022 | 11.79% |
| Sep 30, 2022 | -10.23% |
| Jun 30, 2022 | -12.56% |
| Mar 31, 2022 | -11.96% |
| Dec 31, 2021 | -45.00% |
| Sep 30, 2021 | 2.73% |